Companies: 10,795·Total market cap: $144.5T
MetaVia Inc.

MetaVia Inc.

MTVANASDAQHealthcare● Active
$2.22
$-0.35(-13.62%)
Market Cap$4887215
P/E Ratio—
52W High$19.03
52W Low$0.966
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

MetaVia Inc. (MTVA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MTVA · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-6.03mtva eps ttm · mtva earnings per shareEarnings history
PE Ratio (TTM)—mtva pe ratio ttm · mtva price to earningsPE Ratio deep dive
Revenue (TTM)0.00mtva revenue ttm · mtva annual revenueFull revenue history
Dividend YieldNo Dividenddoes mtva pay dividends · mtva dividend yieldDividend history
Shares Outstanding1.8Mmtva shares outstanding · mtva floatShares outstanding history
Next EarningsAug 6, 2026Est.mtva earnings date · mtva next earningsEarnings history

Explore MetaVia Inc. Data

mtva stock data · financials
Market Cap$4.9Mmtva market cap · mtva valuation
Analyst Forecast$— · Buy
DividendsNo Dividenddoes metavia inc. pay dividends · mtva dividend yield
Revenue—metavia inc. annual revenue · mtva revenue
EarningsEPS $-7.35+81.23%mtva earnings · mtva eps
PE Ratio—mtva pe ratio · mtva price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
metavia inc. revenue · mtva revenue 2025
FY 2025Net Income-$13.0M▲ +52.98% YoY
202320242025
metavia inc. net income · mtva profit 2025
FY 2025EPS$-7.35▲ +81.23% YoY
202320242025
mtva eps · metavia inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$13.1MEPS: $-6.03View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis mtva a buy · mtva analyst rating
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$2.22Current
$—Avg Target
$—High
mtva price target · mtva 12 month forecast

Total: 2 · Buy rate: 100.0%

Stock Performance

Full History
1D-13.62%
1W-18.38%
1M+103.67%
3M+43.23%
YTD-73.63%
1Y-71.93%
5Y-92.02%

About MetaVia Inc.

CEOHyung Heon Kim
IPO DateAug 5, 2016
Employees9
CountryUS
Websitemetaviatx.com

MetaVia Inc. Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardi…

BiotechnologyHealthcareNASDAQUS

what is metavia inc. · mtva stock overview · metavia inc. company profile · who is metavia inc. ceo · mtva NASDAQ · metavia inc. headquarters · metavia inc. business segments

About Stock Overview & Key Data

MetaVia Inc. (MTVA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 5, 2016. As of the latest trading session, MTVA stock price is $2.22, with a market capitalization of $4.9M. The stock has returned -71.93% over the past 12 months and -73.63% year-to-date.

According to 2 Wall Street analysts, the consensus rating for MetaVia Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, MetaVia Inc. reported revenue of — and net income of -$13.0M. For detailed data — including MetaVia Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, MetaVia Inc. (MTVA) stock price is $2.22. The stock is traded on NASDAQ under the ticker symbol MTVA. The 52-week range is $0.97 – $19.03.

MTVA stock priceMTVA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice